Skip to main content

Table 4 Hemodynamics

From: Influence of an acetate- and a lactate-based balanced infusion solution on acid base physiology and hemodynamics: an observational pilot study

  

BL

T60

T120

ІΔ120І

  

Mean ± SD

95% CI

Mean ± SD

95% CI

Mean ± SD

95% CI

Mean ± SD

Norepinephrine requirements (mg/hour)

RL*

0.1 ± 0.1

(0.04-0.16)

0.3 ± 0.2

(0.17-0.43)

0.4 ± 0.3

(0.21-0.59)

0.3 ± 0.3

 

ABIS*

0.1 ± 0.1

(0.04-0.16)

0.3 ± 0.2

(0.17-0.43)

0.5 ± 0.4

(0.25-0.75)

0.41 ± 0.4

Urine-Quantity (ml)

RL*

8.3 ± 19.4

(−4.03-20.63)

210.8 ± 165.2

(105.84-315.76)

630.8 ± 422.2

(362.5-899.0)

622.5 ± 404.4

 

ABIS*

15.8 ± 31.7

(−4.34-35.94)

216.6 ± 153.3

(119.20-314.00)

533.3 ± 286.2

(351.4-715.1)

517.5 ± 271.6

HR (min-1)

RL

55.2 ± 10.9

(48.27-62.13)

56.1 ± 11.8

(48.60-63.60)

58.7 ± 13.6

(50.06-67.34)

3.5 ± 5.3

 

ABIS

55.0 ± 6.3

(51.00-59.00)

60.8 ± 10.4

(54.19-67.41)

59.9 ± 13.9

(51.07-68.73)

4.9 ± 10.0

MAP mmHg)

RL

86.4 ± 8.9

(80.75-92.05)

85.5 ± 11.7

(78.07-92.93)

84.4 ± 11.5

(77.09-91.71)

2.0 ± 11.2

 

ABIS

88.9 ± 13.3

(80.45-97.35)

94.1 ± 15.7

(84.12-104.08)

91.3 ± 15.0

(81.77-100.83)

2.4 ± 14.8

CVP (mmHg)

RL*

11.2 ± 2.3

(9.74-12.66)

10.7 ± 3.5

(8.48-12.92)

8.8 ± 3.5

(6.58-11.02)

2.4 ± 3.4

 

ABIS

10.9 ± 3.2

(8.87-12.93)

12.7 ± 5.3

(9.33-16.07)

11.4 ± 4.4

(8.60-14.20)

0.57 ± 5.4

  1. ABIS, acetate-based infusion solution; BL, baseline measurement; CVP, central venous pressure; HR, heart rate; MAP, mean arterial pressure; RL, Ringer’s lactate; SD, standard deviation; T60, T120, measurement at 60 ± 10 and 120 ± 10 minutes; 95% CI, 95% confidence interval of means; І Δ120 І, absolute value of the difference between T120 and baseline measurements; *, significant intragroup changes over time (P < 0.05) between BL and T120.